Envista (NVST) vs Stevanato Group S.p.A. (STVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Envista (NVST) has outperformed Stevanato Group S.p.A. (STVN) over the past year, gaining 12.8% versus a loss of 19.2%. Over five years, STVN leads with a -20.1% price change compared with -40.5% for NVST. Stevanato Group S.p.A. is the larger company by market cap ($5.27 billion vs $3.60 billion), about 1.5 times the size.
On valuation, Envista trades at a lower forward P/E (13.5x vs 23.1x for Stevanato Group S.p.A.).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NVST | STVN |
|---|---|---|
| Share price | $22.44 | $19.30 |
| Market cap | $3.60B | $5.27B |
| 1-day change | -2.60% | -0.72% |
| YTD return | +6.13% | -3.38% |
| 1-year return | +12.83% | -19.20% |
| 5-year return | -40.50% | -20.07% |
| P/E ratio (TTM) | 38.69 | 33.86 |
| Forward P/E | 13.48 | 23.13 |
| EPS (TTM) | $0.58 | $0.57 |
| Dividend yield | 0.00% | 0.32% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.72B | — |
| Revenue growth (YoY) | +8.32% | — |
| Net income (latest FY) | $47.00M | — |
| Gross margin | 54.67% | — |
| Operating margin | 7.95% | — |
| Net margin | 1.73% | — |
| 52-week high | $30.42 | $27.99 |
| 52-week low | $18.77 | $12.89 |
| Distance from 52-week high | -26.23% | -31.05% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +32.31% | +27.88% |
| Average volume | 2.81M | 370.27K |
| Shares outstanding | 160.62M | 49.83M |
| Employees | 12,000 | 6,010 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NVST has outperformed STVN by 32.0 percentage points over the past year.
About Envista
NVST stock →Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Health Care · Medical/Dental Instruments · 12,000 employees
About Stevanato Group S.p.A.
STVN stock →Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 6,010 employees
NVST vs STVN FAQ
Which is bigger, Envista or Stevanato Group S.p.A.?
Stevanato Group S.p.A. (STVN) is larger, with a market capitalization of $5.27B compared with $3.60B for Envista (NVST).
Which stock has performed better over the past year, NVST or STVN?
NVST returned +12.83% over the past 12 months, compared with -19.20% for STVN (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, NVST or STVN?
STVN has the lower trailing P/E at 33.9, versus 38.7 for NVST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Envista or Stevanato Group S.p.A.?
Stevanato Group S.p.A. pays a dividend yielding 0.32%, while Envista does not currently pay a regular dividend.
Are Envista and Stevanato Group S.p.A. in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.